Abstract
Background
The liver surgeon’s decision to operate is based on imaging studies. However, no clear practical guidelines are available enabling surgeons to safely predict tumor-free margins after a partial hepatectomy. The aim of this retrospective study is to provide surgeons with simple and easily applicable practical guidelines.
Methods
We retrospectively stringently selected 42 anatomical right or left hepatectomies whose main characteristic was to pass along the median hepatic vein, which was preserved. This vein is an easily visualized anatomical landmark on preoperative imaging and is never transgressed by the surgeon. We compared the minimum distance between the tumor and this vein measured on preoperative imaging, and the minimum tumor-free excision margin measured on the specimen by the pathologist.
Results
The median tumor-free excision margin was 5 mm at pathological analysis, significantly different (P < .0001) from the tumor-free margin measured on preoperative imaging (15 mm). The mean difference between these two measurements was 10 ± 4 mm (median, 9 mm). This difference was partly the result of the transection and partly the result of technical deviations in relation to the ideal resection line.
Conclusions
The liver surgeon must consider that roughly a 5 to 8 mm tumor-free margin will disappear during hepatectomy when comparing measurements on the basis of preoperative imaging versus tumor-free specimen margins. If the histologically assessed minimum 2-mm tumor-free margin is added, the surgeon must plan to have a 7 to 10 mm tumor-free margin on preoperative imaging. However, few technical solutions exist that would enable the surgeon to increase the safety margin in borderline cases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ekberg H, Tranberg KG, Andersson R, et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg 1986;73:727–31
Hughes KS. Registry of hepatic metastases. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery 1988;103:278–87
Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal metastases to the liver. A prognostic scoring system to improve case selection based on 1568 patients. Cancer 1996;77:1254–62
Fong Y, Cohen MA, Fortner GJ, et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938–46
Elias D, Cavalcanti A, Sabourin JC, Pignon JP, Ducreux M, Lasser P. Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases. J Surg Oncol 1998;69:88–93
Pawlik T, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005;241:715–24
Figueras J, Burdio F, Ramos E, et al. Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections. Ann Oncol 2007;18:1190–5
Bodingbauer M, Tamandi D, Schmid K, Plank C, Schima W, Gruenberger T. Size of the surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg 2007; 94:1133–8.
Kokudo N, Miki Y, Sugai S, et al. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma. Arch Surg 2002;137:833–40
Elias D, Liberale G, Vernerey D, et al. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 2005;12:1–10
Adam R, Pascal G, Castaing D, et al. Tumor progression while on chemotherapy. A contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004;240:1052–64
Rutherford EE, Karanjia ND. The measurement of liver resection margins. HPB 2004;6:18–20
Takayama T, Makuuchi M, Kubota K, et al. Randomized comparison of ultrasonic vs clamp transection of the liver. Arch Surg 2001;136:922–8
Elias D, Sideris L, Pocard M, et al. Incidence of unsuspected and treatable metastatic disease associated with operable colorectal liver metastases discovered only at laparotomy (and not treated when performing percutaneous radiofrequency ablation). Ann Surg Oncol 2005;12:298–302
Ouellet JF, Pessaux P, Pocard M, Elias D. Transmetastasis curative liver resection immediately following radiofrequency destruction. J Surg Oncol 2002;81:108–10
Elias D, Manganas D, Benizri E, et al. The trans-metastasis hepatectomy (through metastases previously ablated with radiofrequency): results of a 13-case study of colorectal cancer. J Surg Oncol 2006;93:8–12
Elias D, Manganas D, Benizri E, et al. Trans-metastasis hepatectomy: results of a 21-case study. Eur J Surg Oncol 2006;32:213–7
Elias D, El Otmany A, Goharin A, Attalah D, de Baere T. Intraductal cooling of the main bile ducts during intraoperative radiofrequency ablation. J Surg Oncol 2001;76:297–300
Elias D, Pocard M, Sideris L, Dromain C, De Baere T. Intraductal cooling of the main hepatic ducts during radiofrequency ablation prevents biliary stenosis. J Am Coll Surg 2004;198:717–21
Morioka D, Tanaka K, Sekido H, et al. Disruption of the middle hepatic vein is not crucial for liver regeneration of the remnant liver after right hemihepatectomy for hepatic tumors. Ann Surg Oncol 2006;13:1560–8
Acknowledgment
We thank Lorna Saint Ange for editing.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Elias, D., Bonnet, S., Honoré, C. et al. Comparison Between the Minimum Margin Defined on Preoperative Imaging and the Final Surgical Margin After Hepatectomy for Cancer: How to Manage It?. Ann Surg Oncol 15, 777–781 (2008). https://doi.org/10.1245/s10434-007-9697-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-007-9697-9